Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06403501
Status:
RECRUITING
Last Update Posted:
2024-06-05
First Post:
2024-04-30
Brief Title:
Efficacy and Safety of Clascoterone Cream 1 in Facial Acne Vulgaris
Sponsor:
Zhejiang Sunshine Mandi Pharmaceutical CoLtd
Organization:
Zhejiang Sunshine Mandi Pharmaceutical CoLtd
Study Overview
Official Title:
A Multicenter Randomized Double-Blind Vehicle-Controlled Clinical Study to Evaluate the Efficacy and Safety of Clascoterone Cream 1 in Treatment of Subjects With Facial Acne Vulgaris
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective of this study is to determine the safety and efficacy of clascoterone cream 1 versus the vehicle cream applied twice daily for 12 weeks in subjects with facial acne vulgaris
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None